Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02914054Phase 3Completed
Phase 3, randomised, open-label trial of dexamethasone in immune thrombocytopenia (ITP) (2 arms). Primary endpoint: Platelet count. Started Oct 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02914054.